Show simple item record

dc.creatorSwanson, James
dc.creatorArnold, L. Eugene
dc.creatorKraemer, Helena
dc.creatorHechtman, Lily
dc.creatorMolina, Brooke
dc.creatorHinshaw, Stephen
dc.creatorVitiello, Benedetto
dc.creatorJensen, Peter
dc.creatorSteinhoff, Ken
dc.creatorLerner, Marc
dc.creatorGreenhill, Laurence
dc.creatorAbikoff, Howard
dc.creatorWells, Karen
dc.creatorEpstein, Jeffery
dc.creatorElliott, Glen
dc.creatorNewcorn, Jeffery
dc.creatorHoza, Betsy
dc.creatorWigal, Timothy
dc.date.accessioned2012-03-14T19:21:22Z
dc.date.available2012-03-14T19:21:22Z
dc.date.issued2008
dc.identifier.citationJames Swanson et al, "Evidence, Interpretation, and Qualification From Multiple Reports of Long- Term Outcomes in the Multimodal Treatment Study of Children With ADHD (MTA) Part II: Supporting Details," Journal of Attention Disorders 12, no. 1 (2008), doi:10.1177/1087054708319525en_US
dc.identifier.issn1087-0547
dc.identifier.urihttp://hdl.handle.net/1811/51586
dc.description.abstractObjective: To review and provide details about the primary and secondary findings from the Multimodal Treatment study of ADHD (MTA) published during the past decade as three sets of articles. Method: In the second of a two part article, we provide additional background and detail required by the complexity of the MTA to address confusion and controversy about the findings outlined in part I (the Executive Summary). Results: We present details about the gold standard used to produce scientific evidence, the randomized clinical trial (RCT), which we applied to evaluate the long-term effects of two well-established unimodal treatments, Medication Management (MedMGT) and behavior therapy (Beh), the multimodal combination (Comb), and treatment “as usual” in the community (CC). For each of the first three assessment points defined by RCT methods and included in intent-to-treat analyses, we discuss our definition of evidence from the MTA, interpretation of the serial presentations of findings at each assessment point with a different definition of long-term varying from weeks to years, and qualification of the interim conclusions about long-term effects of treatments for ADHD based on many exploratory analyses described in additional published articles. Conclusions: Using a question and answer format, we discuss the possible clinical relevance of the MTA and present some practical suggestions based on current knowledge and uncertainties facing families, clinicians, and investigators regarding the long-term use of stimulant medication and behavioral therapy in the treatment of children with ADHD. (J. of Att. Dis. 2008; 12(1) 15-43)en_US
dc.language.isoen_USen_US
dc.publisherSage Publications Ltd.en_US
dc.rights© 2008 Sage Publications Ltd.en_US
dc.titleEvidence, Interpretation, and Qualification From Multiple Reports of Long- Term Outcomes in the Multimodal Treatment Study of Children With ADHD (MTA) Part II: Supporting Detailsen_US
dc.typeArticleen_US
dc.identifier.doi10.1177/1087054708319525
dc.identifier.osuauthorarnold.6


Files in this item

Thumbnail

Items in Knowledge Bank are protected by copyright, with all rights reserved, unless otherwise indicated.

This item appears in the following Collection(s)

Show simple item record